The Reply to the Letter to the Editor Regarding: "The Autologous CaTeVac Dendritic Cell Vaccine in Patients with Melanoma: Final Results of the DENDRON-01 Study". Voprosy onkologii, v. 72, n. 1, p. OF-2568, 11 Mar.2026.